Our MyTherapy software platform is the Operating System for Digital Therapeutics℠ (DTx). It enables our partners to focus on designing effective DTx algorithms and interventions and to have their DTx benefit from impact proven in studies and with millions of patients.
Modular and configurable platform services and an agile approach to QM and RA reduce time-to-market and enable rapid global deployment under MDR, FDA, and beyond. Our team of behavioral scientists, designers, medical writers, and data scientists supports intervention design, patient recruiting, and clinical evaluation as needed.
Want to see it in action?
Request a demoBuilding powerful applications is just so much easier with an operating system in place. Innovators from pharma, MedTech, and academia leverage the MyTherapy platform as the operating system for their DTx, so they can focus on developing its therapeutic/diagnostic nucleus. While maintaining ownership of their IP, they benefit from configurable platform elements, built-in regulatory compliance, and the outstanding engagement of the MyTherapy app.
With MyTherapy, you can run your DTx in an environment proven with millions of users, 4.8 out of 5 stars average rating, and agile improvements applied through more than 300 releases. If engagement matters for your DTx, building on MyTherapy saves you years of agile refinements to your user experience.
Any DTx needs a lot of underlying basics: Robust notifications, connectivity with Google Fit and Apple Health, a chatbot interface, and many more. You can build and maintain all of these yourself. Or you can plug into MyTherapy, consume them as a service, and focus on interventions that deliver improved health outcomes.
Being medical device software, DTx requires quality management as per ISO 13485. To avoid compromising on agility, we take a sandbox approach, whereby the medical device runs as a dedicated module in a validated environment. All non-medical device features run outside this sandbox and benefit from agile refinements.
Time matters when bringing a DTx to market. Tap into our platform-enabled services to accelerate every step of development and deploy your DTx to more markets, faster.
Insights from more than 3 million users and more than 1 billion data points enable you to pinpoint patients’ real-world needs and to identify digital biomarkers. By dispatching surveys to patients in relevant therapeutic areas, you can further validate your DTx's proposition.
Tap into our experience for intervention design, grounded in behavior change methodology. Apply our design phase blueprint to rapidly create technical documentation and initial version and test in formative study.
Accelerate clinical evaluation through innovative study setups and by recruiting patients from the MyTherapy user base. Get support in study design and management from our health scientists.
If you want to be the DTx manufacturer, we supply you with technical documentation ready for submission with your Notified Body, FDA, etc. If we are the manufacturer of your DTx, we also handle the submission process.
Market access considerations typically already shape the discovery phase. Once approved to the market, we can support you with real-world data and analytics for proving your DTx’s value towards payors.
Operating a medical device takes expertise and continuous effort. Beyond technical operation, we can help with handling of feedback and complaints as well as with post-market surveillance activities.
DTx success takes more than brilliant science and engineering. We can support you with to-the-point and compliant messaging and materials. By strictly leaving distribution/sales to our partners, we avoid conflicts of interest.
